Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 1 | uM | 8 | 5000.00 | 1193.65 | 6868.00 | 7393.25 | 0.9290 | 0.9448 |
| BT-20 | Linsitinib | 10 | uM | 8 | 5000.00 | 1193.65 | 6331.00 | 7393.25 | 0.8563 | 0.8855 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 5000.00 | 1193.65 | 5722.00 | 7393.25 | 0.7740 | 0.8144 |
| BT-20 | Erlotinib | 10 | uM | 8 | 5000.00 | 1193.65 | 4609.00 | 7393.25 | 0.6234 | 0.6712 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 5000.00 | 1193.65 | 7266.00 | 7393.25 | 0.9828 | 0.9868 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 5000.00 | 1193.65 | 7253.00 | 7393.25 | 0.9810 | 0.9855 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 5000.00 | 1193.65 | 6439.00 | 7393.25 | 0.8709 | 0.8977 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 5000.00 | 1193.65 | 6155.00 | 7393.25 | 0.8325 | 0.8654 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 5000.00 | 1193.65 | 7389.00 | 7393.25 | 0.9994 | 0.9996 |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7527.00 | 7393.25 | 1.0181 | 1.0137 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 5000.00 | 1193.65 | 7342.00 | 7393.25 | 0.9931 | 0.9947 |
| BT-20 | Linsitinib | 1 | uM | 8 | 5000.00 | 1193.65 | 7160.00 | 7393.25 | 0.9685 | 0.9758 |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7171.00 | 7393.25 | 0.9699 | 0.9769 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7244.00 | 7393.25 | 0.9798 | 0.9846 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 6745.00 | 7393.25 | 0.9123 | 0.9314 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7310.00 | 7393.25 | 0.9887 | 0.9914 | |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 5000.00 | 1193.65 | 5397.00 | 7393.25 | 0.7300 | 0.7745 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 5000.00 | 1193.65 | 6915.00 | 7393.25 | 0.9353 | 0.9498 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 5000.00 | 1193.65 | 7233.00 | 7393.25 | 0.9783 | 0.9834 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 5000.00 | 1193.65 | 7539.00 | 7393.25 | 1.0197 | 1.0149 |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 5000.00 | 1193.65 | 7668.00 | 7393.25 | 1.0372 | 1.0279 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 5000.00 | 1193.65 | 7796.00 | 7393.25 | 1.0545 | 1.0407 |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7467.00 | 7393.25 | 1.0100 | 1.0076 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 5000.00 | 1193.65 | 7423.00 | 7393.25 | 1.0040 | 1.0031 |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7381.00 | 7393.25 | 0.9983 | 0.9987 |